Due to caution against Trump's tariffs, it temporarily fell below the milestone of 38,000 yen.

The Nikkei average continued to decline. It finished trading at 38,134.97 yen, down 307.03 yen (volume estimated at 1.8 billion 20 million shares). Today, risk-averse selling continued against the backdrop of concerns over the global economy due to the upcoming Trump administration's tariff increases. Additionally, the yen appreciated, reaching the low 152 yen range against the dollar, negatively impacting export-related stocks, which caused the Nikkei average to widen its decline towards the end of the afternoon session, pushing down to 37,988.99 yen and dipping below the psychological threshold of 38,000 yen.

Fisco JapanNov 27 02:30 ET

Active and newly established stocks in the afternoon session.

* Advantest <6857> 8506 -328 fell below the 25-day moving average the previous day, also leading to sell-offs. * Monster Lab <5255> 117 -2 became temporarily popular due to participating in the development of KDDI's retail AI promotional technology solution, but the buying did not continue. * Pixel CZ <2743> 79 +16 signed a sales contract for GPU servers equipped with NVIDIA's H100. * GNI <2160> 2953 +145 the stock price of the consolidated subsidiary involved in the reverse merger has increased.

Fisco JapanNov 27 02:10 ET

Active and newly listed stocks during the morning session.

*Dai-Doo Group HD <2590> 3240 +326 The cumulative operating profit for the third quarter has turned into an increase. *Janome <6445> 1187 +82 The upward trend in stock prices continues, and buybacks are becoming more active. *Keisei Electric Railway <9009> 4662 +243 Viewed as a material for the sale of shares in OLC shareholding. *Resonac <4004> 4170 +178 Interest as a related company to perovskite solar cells. *Oriental Land Co., Ltd. Unsponsored ADR <4661> 3585 +150 Responding to the sale of shares in Keisei Electric Railway.

Fisco JapanNov 27 00:03 ET

Lion, Kobayashi Pharmaceutical, etc (additional) Rating

Target stock price change code stock name securities company previous changed after --------------------------------------------- <2607> Fuji Oil SMBC Nikko 3800 yen 4200 yen <2802> Ajinomoto SMBC Nikko 6800 yen 7200 yen <4043> Tokuyama Mizuho 3200 yen 3300 yen <4183> Mitsui Chemicals Nomura 4500 yen 4730 yen <4506> Sumitomo Pharma SMBC Nikko 600 yen 650 yen <4552> JCR Pharma

Fisco JapanNov 26 21:28 ET

DELTA-P has ranked in, recognized as a recommended treatment method in the 'Lung Cancer Treatment Guidelines 2024' for Afatinib.

DELTA-P＜4598＞ has ranked in (as of 9:32 AM). It saw a significant rise at one point. After the trading session ended the previous day, the Japan Lung Cancer Society announced that in the "Lung Cancer Treatment Guidelines 2024 Edition" published on October 20, 2024, afatinib, which is used in the clinical Phase III comparison trial of DFP-14323 conducted by the company, is stronger than osimertinib for the first-line treatment of non-small cell lung cancer (NSCLC) with positive epidermal growth factor receptor (EGFR) gene mutation uncommon mutation.

Fisco JapanNov 26 19:38 ET

November 27th [Today's investment strategy]

[Fisco Selected Stocks] [Material Stocks] Asentec <3565> 652 yen (11/26) engages in the development of products related to virtual desktops. The performance financial estimates for the fiscal year ending January 2025 have been revised upwards. The operating profit is estimated to be 0.93 billion yen (an increase of 56.2% compared to the previous period). This estimation has been raised by about 29% from the previous forecast. The significant increase in revenue from the virtual desktop business area, which includes multiple large projects, contributed to this growth. Additionally, on September 25, a strategic partnership agreement was signed with a major U.S. software company.

Fisco JapanNov 26 18:55 ET